American Healthcare REIT Analyst Price Targets

Wall Street analyst price targets and consensus rating for American Healthcare REIT (AHR).

Price Target Range — 11 Quarters

Analyst Consensus — 15 Analysts

3S.Buy

12Buy

Consensus RatingBuy# Analysts15Avg. Consensus PT$49Upside to Avg. PT-2.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$56→$62
Aug 31, 2026	Barclays	Richard Hightower	PT Raise	Overweight	$61→$66
Aug 19, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$58→$68
Aug 14, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$57→$61
Aug 14, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$56→$61
Aug 13, 2026	Citigroup	Nick Joseph	PT Raise	Buy	$55→$65
Jul 27, 2026	Citizens	Aaron Hecht	PT Raise	Market Outperform	$60→$65
Jul 21, 2026	Compass Point	Rob Simone	Initiate	Buy	$70
Jul 8, 2026	UBS	Michael Goldsmith	PT Raise	Buy	$60→$63
Jul 7, 2026	Barclays	Richard Hightower	Initiate	Overweight	$61
Jun 23, 2026	Citigroup	Nick Joseph	Upgrade	Neutral→Buy	$55
Jun 18, 2026	Scotiabank	Nicholas Yulico	PT Cut	Sector Outperform	$59→$51
May 28, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$55→$58
May 26, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$54→$56
Mar 13, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$52→$57
Mar 11, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$55→$59
Mar 2, 2026	Citigroup	Nick Joseph	PT Raise	Neutral	$52→$55
Feb 5, 2026	Citizens	Aaron Hecht	Maintained	Market Outperform	$60
Jan 29, 2026	BMO Capital	Juan Sanabria	Initiate	Outperform	$55
Jan 20, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$53→$52

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and raises the price target from $56 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68

Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $58 to $68.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61

Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $57 to $61.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61

RBC Capital analyst Michael Carroll maintains American Healthcare REIT (NYSE:AHR) with a Outperform and raises the price target from $56 to $61.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $65

Citigroup analyst Nick Joseph maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $55 to $65.

Benzinga Newsdesk

American Healthcare REIT Inc

뉴스

파트너 / 기고자

벤징가 글로벌

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

PRO
Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68

PRO
Truist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $65

People Also Watch

People Also Watch

American Healthcare REIT Inc

뉴스

파트너 / 기고자

벤징가 글로벌

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROScotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

PROKeybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68

PROTruist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61

PRORBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61

PROCitigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $65

People Also Watch

People Also Watch

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

PRO
Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68

PRO
Truist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61

PRO
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61

PRO
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $65